Biotech & Life Sciences

The Biotech & Life Sciences Investment Committee represents expertise in drug development, clinical therapy, and medical device technologies and the wider biotechnology space.

Our Biotech & Life Sciences Investment Committee

Hon Pete Hodgson - Chair

Chair Callaghan Innovation

Julia Chambers

Board Director

Company Advisor

Technology Investor

Mike Bickerdike

CSO Kea Therapeutics

Drug Discovery & Development Consultant

Colin Dawson

Chairman

Upstream Medical Technologies

Phil Kearney

Director

Merck

Nour Ghamri
Cancer Research PhD Student
University of Auckland

Kjesten Wiig

Director of Innovation Partnerships

MBIE

Jim Mervis

Director

Lung Therapeutics

Will Charles

Executive Director of Commercialisation

UniServices

Andy Shenk

CEO

UniServices

Mackenzie Nicol

Senior Investment Manager

MBIE

 

Andrew Wilks

CEO & Executive Chairman

SYNthesis Research

Josh Funder

CEO & Managing Director

Household Capital

Duncan Mackintosh

Investment Manager

Brandon Capital Partners

Margaret Brimble

Distinguished Professor

University of Auckland

Ken Taylor

CEO

Living Cell Technologies

Evelyn Body

Director of Commercialisation

UniServices

Dick Bellamy

Independent Research Professional

Elliot Dunn

Bioengineering PhD Student

University of Auckland

John Villiger

Company Director

UniServices